110 studies on Melanocortin agonist class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research reveals a previously unknown feedback loop where melanocortin activation, while suppressing appetite overall, also stimulates a neural circuit that counteracts this effect. For peptide users, this implie…
This research provides a powerful new toolkit for drug developers and researchers studying peptide ADME properties. For those investigating peptides like Melanotan II, this combined methodology offers a way to see exa…
This analysis provides a critical public health framework: monitoring the drug use trends within the niche community of pioneering bodybuilders can serve as an early warning system for substances that may become probl…
This innovative approach offers a promising strategy to overcome the critical challenge of drug resistance in melanoma by enabling the use of diverse cytotoxic drugs with low inherent resistance issues. By leveraging …
This research is significant as it demonstrates that activating the melanocortin system with Melanotan II can partially mitigate the severe thermoregulatory deficits observed in PACAP-deficient mice. This suggests a n…
This case serves as a critical safety warning for individuals using illicitly obtained Melanotan II for tanning or sexual enhancement. Priapism, particularly the ischemic type, is a medical emergency that can lead to …
These findings highlight the melanocortin system as a promising therapeutic target for Alzheimer's disease, moving beyond symptomatic treatment to address core pathologies like amyloid burden and neuroinflammation. Fo…
This research identifies a previously unrecognized brain circuit involving the Mes5 and NTS POMC neurons that plays a crucial role in regulating appetite and body weight. Understanding this pathway could open new aven…
This case report critically underscores the immediate and potentially life-threatening systemic risks associated with the unregulated self-administration of Melanotan II. Despite its widespread availability through on…
This groundbreaking study provides compelling evidence that even a relatively short-term high-fat diet can significantly impact both memory and emotional states. The finding that Melanotan-II (MT-II) effectively rever…
This research represents a significant advance in peptide drug design, offering a powerful new strategy to create more stable and potent peptide therapeutics. By mimicking robust natural product structures, this metho…
This research identifies [Ac-CKPV]2 as a highly promising candidate for the development of new therapies for fungal infections, particularly those caused by drug-resistant Candida strains which are difficult to treat.…
This research highlights the significant therapeutic potential of melanocortin peptides in addressing unmet medical needs. The development of MTI could offer a novel, preventative approach to skin cancer through induc…
**Bremelanotide's ability to improve self-reported desire and intercourse-related arousal satisfaction without requiring a physiological vasocongestion signal** suggests its mechanism is primarily central — a meaningf…
**Central MC receptor activation via PT-141 offers a mechanistically distinct alternative to PDE5 inhibitors**, potentially benefiting patients who fail vascular-targeted therapies or who present primarily with reduce…
**Bremelanotide's central mechanism of action** — activating `melanocortin receptors` in the hypothalamus rather than relaxing peripheral vasculature — means it avoids the hypotensive liability that limits PDE5 inhibi…
**Bremelanotide's CNS mechanism differentiates it from all currently available FSD treatments**, which predominantly target hormonal or vascular pathways — making it a potentially valuable addition where those approac…
This review highlights the untapped potential of targeting the central nervous system for treating sexual dysfunction, offering a complementary approach to existing peripheral treatments. By modulating key neurotransm…
This retraction highlights the critical importance of research integrity and transparency in scientific publishing. Unverified or fraudulent data can mislead future research and potentially harm patients if treatments…
**Clinicians managing sildenafil non-responders now have preliminary randomized evidence for a mechanistically distinct intranasal peptide option.** Because bremelanotide acts centrally via `MC3R`/`MC4R` rather than t…
This review highlights a paradigm shift in treating male sexual dysfunction, moving beyond peripheral mechanisms to target the central nervous system. By modulating neurohormones and neurotransmitters, these agents co…
**Bremelanotide's appearance in a multi-compound clinical-trials digest** places it on the map of agents that had sufficiently advanced development programs to warrant monitoring by major drug-intelligence platforms. …
The review identified nasal apomorphine and bremelanotide as the most promising centrally acting agents with significant potential for future approval in erectile dysfunction (ED) treatment. While several other agents…
This review consolidates the evidence for melanocortin agonists as a viable treatment class for both male and female sexual dysfunctions, offering a centrally-acting alternative to peripheral-focused drugs. For indivi…
This review consolidates the neurobiological framework for understanding **HSDD**, shifting the focus from purely psychological or hormonal models to a central nervous system-based approach. For clinicians and patient…
This study provides strong evidence that bremelanotide is a safe, effective, and well-tolerated treatment for female sexual dysfunctions in premenopausal women. The significant improvements in satisfying sexual events…
This review provides a crucial overview for clinicians and patients navigating the difficult landscape of **HSDD** treatment. It positions bremelanotide (PT-141) within a broader context of available therapies, sugges…
This review reinforces the understanding that female sexual desire is not just hormonal but is deeply rooted in central nervous system neurochemistry, particularly the balance between serotonin and dopamine. For indiv…
This review provides a structured clinical framework for addressing HSDD, a condition often overlooked. For clinicians and patients, it clarifies the diagnostic pathway and summarizes the limited therapeutic landscape…
This study provides robust validation for the **1.75 mg dose of bremelanotide** as an effective treatment for premenopausal women with HSDD. The multiple responder analyses offer a sophisticated framework for interpre…
The approval of bremelanotide represents a pivotal advancement in addressing a significant unmet medical need for women experiencing HSDD. Its unique profile as a self-administered, on-demand subcutaneous therapy offe…
This research provides critical data for the development of alternative bremelanotide formulations, indicating that standard oral administration is likely ineffective. For users or developers, this strongly suggests t…
This validation provides a new, reliable tool for both researchers and clinicians to more accurately measure sexual desire in women with HSDD. For individuals using or considering peptides like bremelanotide, the EDQ …
This research highlights the critical role of advanced analytical techniques in combating the illegal trade of unapproved drugs, which often pose significant health risks to users. The successful identification of mel…
This review clarifies the specific neurobiological target for bremelanotide, moving beyond a general understanding to pinpoint its action on `MC4R` in the hypothalamus and subsequent dopamine release. For clinicians a…
This study's qualitative data provides crucial context to the quantitative efficacy demonstrated in the main clinical trials. For clinicians and patients, it clarifies that bremelanotide's effects are not merely stati…
This re-analysis provides a crucial counter-narrative to the initial positive reporting on bremelanotide for **HSDD**. For clinicians and potential users, it highlights that the drug's modest benefits on desire may no…
This critical analysis underscores the urgent need for reconsideration of regulatory decisions regarding these drugs, given their questionable efficacy. The findings highlight how politicized industry-sponsored advoca…
This comprehensive review provides a vital resource for healthcare professionals, offering much-needed clarity on the diverse medical treatments available for Female Sexual Dysfunction (FSD). By clearly outlining spec…